发明名称 |
(-)-5-(3-Chlorophenyl)-[alpha]-(4-chlorophenyl)-[alpha]-(1- methyl-1H-imidazol-5-yl)tetrazolo-[1,5-a]quinazoline-7- methanamine, method of preparation and use thereof, pharmaceutical preparation containing it and a method of preparation thereof |
摘要 |
<p>It is described (-)-5-(3-Chlorophenyl)-[alpha]-(4- chlorophenyl)-[alpha]-(1-methyl-1<i>H</i >-imidazol-5- yl)tetrazolo-[1,5-a]quinazoline-7-methanamine and its pharmaceutically acceptable acid addition salts, method of their preparation by separation from particular racemic mixtures and the use of such compounds in medicine especially for the treatment of cancer. It is also described a pharmaceutical preparation containing some of these substances and method of preparation thereof.</p> |
申请公布号 |
SK285699(B6) |
申请公布日期 |
2007.06.07 |
申请号 |
SK20030000050 |
申请日期 |
2001.06.13 |
申请人 |
JANSSEN PHARMACEUTICA N. V. |
发明人 |
VENET MARC GASTON;ANGIBAUD PATRICK RENE;END DAVID WILLIAM |
分类号 |
A61K31/519;A61P35/00;C07D487/04 |
主分类号 |
A61K31/519 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|